Effect of β-adrenergic and renin-angiotensin system blockade on myocyte apoptosis and oxidative stress in diabetic hypertensive rats

Life Sciences

Volumn 81, Issue 12, 2007, Pages 951-959

  Fiordaliso, Fabio ^a   De Angelis, Noeleen ^a   Bai, Antonio ^a   Cuccovillo, Ivan ^a   Salio, Monica ^a   Maria Serra, Domenico ^a   Bianchi, Roberto ^a   Razzetti, Roberta ^b   Latini, Roberto ^a   Masson, Serge ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

adrenergic system; Apoptosis; Diabetes; Hypertension; Oxidative stress; Renin angiotensin system

Indexed keywords

5,6 DIHYDROXY 2 METHYLAMINO 1,2,3,4 TETRAHYDRONAPHTHALENE; 5,6 DIHYDROXY 2 METHYLAMINOTETRALIN; DOPAMINE RECEPTOR STIMULATING AGENT; GLUCOSE; METOPROLOL; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; TEMPOL; VALSARTAN;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC HYPERTENSION; DISEASE ASSOCIATION; DRUG EFFECT; HEART MUSCLE CELL; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; APOPTOSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; HYPERTENSION; MALE; METOPROLOL; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; STREPTOZOCIN; TETRAZOLES; VALINE;

ANIMALIA; RATTUS;

EID: 34548524091     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.05.027     Document Type: Article

References (37)

1. Alderman M.H., Cohen H., and Madhavan S. Diabetes and cardiovascular events in hypertensive patients. Hypertension 33 (1999) 1130-1134
2. Bell D.S. Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade. Current Medical Research and Opinion 21 8 (2005) 1191-2000
3. Cai L., Li W., Wang G., Guo L., Jiang Y., and Kang Y.J. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51 6 (2002) 1938-1948
4. Csonka C., Pataki T., Kovacs P., Muller S.L., Schroeter M.L., Tosaki A., and Blasig I.E. Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts. Free Radical Biology & Medicine 29 7 (2000) 612-619
5. De Angelis N., Fiordaliso F., Latini R., Calvillo L., Funicello M., Gobbi M., Mennini T., and Masson S. Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat. Journal of Molecular and Cellular Cardiology 34 (2002) 1655-1665
6. Diez J., Panizo A., Hernandez M., Vega F., Sola I., Fortuno M.A., and Pardo J. Apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 30 5 (1997) 1029-1034
7. Fiordaliso F., Li B., Latini R., Sonnenblick E.H., Anversa P., Leri A., and Kajstura J. Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent. Laboratory Investigation 80 (2000) 513-527
8. Fiordaliso F., Leri A., Cesselli D., Limana F., Safai B., Nadal-Ginard B., Anversa P., and Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50 10 (2001) 2363-2375
9. Fiordaliso F., Bianchi R., Staszewsky L., Cuccovillo I., Doni M., Laragione T., Salio M., Savino C., Melucci S., Santangelo F., Scanziani E., Masson S., Ghezzi P., and Latini R. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. Journal of Molecular and Cellular Cardiology 37 (2004) 959-968
10. Fortuno M.A., Ravassa S., Fortuno A., Zalba G., and Diez J. Cardiomyocyte apoptotic cell death in arterial hypertension: mechanisms and potential management. Hypertension 38 6 (2001) 1406-1412
11. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., Nadal-Ginard B., and Anversa P. Myocardial cell death in human diabetes. Circulation Research 87 (2000) 1123-1132
12. Gonzalez A., Fortuno M.A., Querejeta R., Ravassa S., Lopez B., Lopez N., and Diez J. Cardiomyocyte apoptosis in hypertensive cardiomyopathy. Cardiovascular Research 59 (2003) 549-562
13. Hypertension in Diabetes Study (HDS). Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. Journal of Hypertension 11 3 (1993) 319-325
14. Kajstura J., Fiordaliso F., Andreoli A.M., Li B., Chimenti S., Medow M.S., Limana F., Nadal-Ginard B., Leri A., and Anversa P. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin-II-mediated oxidative stress. Diabetes 50 (2001) 1414-1424
15. Kavantzas N.G., Lazaris A.C., Agapitos E.V., Nanas J., and Davaris P.S. Histological assessment of apoptotic cell death in cardiomyopathies. Pathology 32 (2000) 176-180
16. 1-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion. Journal of Cardiovascular Pharmacology 31 (1998) 601-608
17. Lindholm L.H., Dahlof B., Edelman J.M., Ibsen H., Borch-Johnsen K., Olsen M.H., Snapinn S., Wachtell K., and LIFE study group. Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study. Lancet 23; 362 9384 (2003) 619-620
18. 1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion. Journal of Cardiovascular Pharmacology 34 (1999) 321-326
19. 2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overload. Cardiovascular Drugs and Therapy 15 (2001) 131-138
20. Mathis D.R., Liu S.S., Rodrigues B.B., and McNeill J.H. Effect of hypertension on the development of diabetic cardiomyopathy. Canadian Journal of Physiology and Pharmacology 78 (2000) 791-798
21. Narula J., Pandey P., Arbustini E., Haider N., Narula N., Kolodgie F.D., Dal Bello B., Semigran M.J., Bielsa-Masdeu A., Dec G.W., Israels S., Ballester M., Virmani R., Saxena S., and Kharbanda S. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America 96 14 (1999) 8144-8149
22. Niskanen L., Hedner T., Hansson L., Lanke J., Niklason A., and CAPPP Study Group. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project. Diabetes Care 24 12 (2001) 2091-2096
23. Park J.B., Touyz R.M., Chen X., and Schiffrin E.L. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. American Journal of Hypertension 15 (2002) 78-84
24. S expression and reduces apoptosis in failing myocardium. Journal of Molecular and Cellular Cardiology 35 (2003) 483-493
25. Rossoni G., Manfredi B., Cavalca V., Razzetti R., Bongrani S., Polvani G.L., and Berti F. The aminotetraline derivative (±)-(R,S)-5,6-dihydro-2-methylamino-1,2,3,4- tetrahydronaphtalene hydrochloride (CHF-1024) displays cardioprotection in postischemic ventricular dysfunction of the rat heart. Journal of Pharmacology and Experimental Therapeutics 307 (2003) 633-639
26. Sampaio R.C., Tanus-Santos J.E., Melo S.E., Hyslop S., Franchini K.G., Luca I.M., and Moreno Jr. H. Hypertension plus diabetes mimics the cardiomyopathy induced by nitric oxide inhibition in rats. Chest 122 (2002) 1412-1420
27. 2α. Hypertension 133 (1999) 424-428
28. Sharma J.N., and Kesavarao U. Effect of captopril on urinary kallikrein, blood pressure and myocardial hypertrophy in diabetic spontaneously hypertensive rats. Pharmacology 64 (2002) 196-200
29. Shiuchi T., Iwai M., Li H.S., Wu L., Min L.J., Li J.M., Okumura M., Cui T.X., and Horiuchi M. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension 43 5 (2004) 1003-1010
30. Shizukuda Y., Buttrick P.M., Geenen D.L., Borczuk A.C., Kitsis R.N., and Sonnenblick E.H. beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. The American Journal of Physiology 275 3 Pt 2 (1998) H961-H968
31. Singh K., Communal C., Sawyer D.B., and Colucci W.S. Adrenergic regulation of myocardial apoptosis. Cardiovascular Research 45 3 (2000) 713-719
32. Somova L.I., Nadar A., Gregory M., and Khan N. Antioxidant status of the hypertrophic heart of Dahl hypertensive rat as a model for evaluation of antioxidants. Methods and Findings in Experimental and Clinical Pharmacology 23 1 (2001) 5-12
33. Swift L.M., and Sarvazyan N. Localisation of dichlorofluorescin in cardiac myocytes: implications for assessment of oxidative stress. The American Journal of Physiology 278 (2000) H982-H990
34. Taniyama Y., and Griendling K.K. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42 (2003) 1075-1081
35. Touyz R.M., Yao G., Viel E., Amiri F., and Schiffrin E.L. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. Journal of Hypertension 22 (2004) 1141-1149
36. Wold L.E., Relling D.P., Colligan P.B., Scott G.I., Hintz K.K., Ren B.H., Epstein P.N., and Ren J. Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes. Journal of Molecular and Cellular Cardiology 33 (2001) 1719-1726
37. Yuan Z., Shioji K., Kihara Y., Takenaka H., Onozawa Y., and Kishimoto C. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property. American Journal of Physiology. Heart and Circulatory Physiology 286 1 (2004) H83-H90